Tourmaline Bio
Brady Hurtgen, PhD, serves as the Sr. Regional Field Medical Director at Tourmaline Bio. Prior to this role, Brady held the position of Field Regional Medical Director for Rare Disease at Amgen and also at Horizon, which was acquired by Amgen in October 2023. With a focus on rare diseases, Brady has extensive experience in the field medical domain.
This person is not in any teams
This person is not in any offices
Tourmaline Bio
2 followers
Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. In doing so, we seek to develop assets medicines that have the potential to establish new standards-of-care in areas of high unmet medical need.